Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05935111 · ClinicalTrials.gov registry record · NA

Physical Activity: Feasibility Study

A NA study of Obesity and Physical Activity, sponsored by Binghamton University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05935111: Recruiting NA study of Obesity and Physical Activity, sponsored by Binghamton University.

NCT05935111 is a NA study of Obesity and Physical Activity that is actively recruiting participants, run by Binghamton University. The registered enrollment target is 30 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05935111, a NA study of Obesity and Physical Activity, is actively recruiting participants, sponsored by Binghamton University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The Physical Activity Self-efficacy (PAS) intervention is a web-based behavioral intervention newly developed to promote physical activity in adults with obesity. The conceptual framework for the PAS intervention is based on self-efficacy theory. The objective of this study is to investigate the feasibility and acceptability of implementing the PAS online intervention for adults with obesity recruited from a local weight management center in the United States of America (USA). The study design is a prospective, double-blind, parallel group randomized pilot trial. Thirty participants will be randomly assigned to the PAS group or usual care group to achieve a 1:1 group assignment. Recruitment of participants is scheduled to begin in January 2024 or earlier at a local weight management center within a private healthcare system in the USA. There are five eligibility criteria for participation in this study (e.g., a body mass index ≥ 25.00 kg/m2). Eligibility verification and data collection will be conducted online. Three waves of data collection will take up to 14 weeks depending on participants' progress in the study. Instruments designed to measure demographic information, anthropometric characteristics, self-efficacy, and acceptability will be included in the survey battery. A research-grade accelerometer will be used to measure free-living physical activity objectively. Data will be analyzed using descriptive statistics and inferential statistical models under an intention-to-treat approach. This study will be sponsored by the Transdisciplinary Areas of Excellence Seed Grant Program from Binghamton University.

Interventions

  • BEHAVIORAL Physical Activity Self-efficacy (PAS) intervention

Study Locations (1)

New York

  • Guthrie - Binghamton

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-01-01
Est. Completion 2024-12-31
Phase NA
Binghamton University

7 total trials

What NCT05935111 shows while recruiting

NCT05935111 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower).

The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Physical Activity Self-efficacy (PAS) intervention is the first listed.

NCT05935111 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05935111 about?

NCT05935111 is a clinical study titled "Physical Activity: Feasibility Study". The Physical Activity Self-efficacy (PAS) intervention is a web-based behavioral intervention newly developed to promote physical activity in adults with obesity. The conceptual framework for the PAS intervention is based on self-efficacy theory. The objective of this study is to investigate the fea...

What is the current status of trial NCT05935111?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-01-01. Estimated completion is 2024-12-31.

What conditions does trial NCT05935111 study?

This clinical trial studies the following conditions: Obesity, Physical Activity, Self Efficacy, Online Intervention, Accelerometers.

What interventions are being tested in trial NCT05935111?

The interventions under investigation include: Physical Activity Self-efficacy (PAS) intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05935111?

This trial is sponsored by Binghamton University, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05935111 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05935111's enrollment target sits among peer trials

30 851st of 1053 higher than 173 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05935111, the US trial registry maintained by the National Library of Medicine. NCT05935111 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.